C12N 2710/16051
Methods of production or purification of viral material
C12N2710/16051 (Methods of production or purification of viral material) appears on 13 US grants and 16 published applications in this corpus.
Search patents in C12N- Granted patents
- 13
- Published applications
- 16
- Assignees
- 24
- Inventors
- 57
- Latest grant
- 6 Jan 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 0 | 1 |
| 2003 | 0 | 0 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 0 | 0 |
| 2007 | 0 | 1 |
| 2008 | 0 | 2 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 2 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 1 |
| 2015 | 0 | 0 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 0 |
| 2019 | 1 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 0 |
| 2022 | 1 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 0 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Methods and systems for manufacturing viral vectors6 Jan 2026US 12,516,349 B2Regeneron Pharmaceuticals, Inc.
- EHV with inactivated UL18 and/or UL812 Jul 2022US 11,384,365 B2
- Bioreactor production of virus from adherent cells1 Dec 2020US 10,851,350 B1Genelux Corporation
- Compositions and methods for the production of alpha-herpesviruses17 Dec 2019US RE47,768 E1Sanofi Pasteur Biologics, LLC
- Koi herpesvirus vaccine3 Apr 2018US 9,931,396 B2Gesval S.A.
- Adeno-Associated Virus Production Platform9 Jul 2026US 2026/0193676 A1MedImmune, LLC
- Modified Herpes Simplex Virus Type 16 Nov 2025US 2025/0340903 A1Eg 427
- Plasmid dna purification methods1 May 2025US 2025/0137024 A1Glaxosmithkline Biologicals SA
- Kaposi sarcoma associated herpesvirus gene function25 Jul 2024US 2024/0248080 A1The Regents of the University of California
- Methods and systems for manufacturing viral vectors7 Apr 2022US 2022/0106610 A1bluebird bio, Inc.
Most cited
By later US patents
- Method of magnetic separation of cells and the like, and microspheres for use therein186US 4,230,685 ANorthwestern University · 1980
- Dichloroacetamides, herbicides containing acetanilides as herbicidal active ingredients and the dichloroacetamides as antagonists, and the use of these herbicides in controlling undesired plant growth8US 4,448,960 ABASF SE · 1984
- Glycolipid adjuvant compositions5US 8,460,679 B2Zoetis LLC · 2013
- Compositions and methods for the production of alpha-herpesviruses5US 8,877,492 B2Sanofi Pasteur Biologics, LLC · 2014
- Dichloroacetamides, herbicides containing acetanilides as herbicidal active ingredients and the dichloroacetamides as antagonists, and the use of these herbicides in controlling undesired plant growth4US 4,565,565 ABASF SE · 1986